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ABSTRACT 
 
The purpose of this study was to explore the possible comparative in-vitro effects of two 
anthroposophical complex preparations on the growth of Staphylococcus aureus. The 
effect of these two anthroposophical complexes, the first being Echinacea/ Quartz 
Complex Single Dose Eyedrops (Wala), and the second being a preparation called 
Euphrasia Single Dose Eyedrops (Wala) on Staphylococcus aureus in-vitro had not yet 
been established. 
 
The two methods employed were the agar dilution method and the disc diffusion method. 
These tests measured the in-vitro susceptibility of the Staphylococcus aureus to the 
anthroposophical complexes and to chloramphenicol (a broad spectrum allopathic anti-
biotic commonly used to treat bacterial conjunctivitis caused by Staphylococcus aureus 
infection). The experiments were conducted on twenty Staphylococcus aureus isolates, 
obtained from Van Drimmelin Laboratories. All experimentation was conducted in 
triplicate in order to eliminate laboratory error. In the agar dilution method, broth cultures 
of the twenty isolates were prepared and equal amounts of the cultures were plated out 
onto the agar media individually treated with the antimicrobial of choice, or onto 
unmedicated agar. After 24 hours of incubation the number of colonies per plate were 
counted. In the disc diffusion test, discs individually impregnated with the antimicrobial of 
choice and unmedicated discs were placed onto inoculated nutrient agar plates. After 24 
hours of incubation the zone diameters were measured. 
 
The results were compared using a two-way analysis of variance. They showed that neither 
of the anthroposophical complexes had a significant in-vitro effect on the growth of 
Staphylococcus aureus in the agar dilution method, and neither complex displayed any 
anti-bacterial action in the disc diffusion test. However, studies have shown that patients 
using these eyedrops to treat bacterial conjunctivitis have experienced significant 
symptomatic relief. Therefore, it is recommended that a follow on in-vivo study be 
conducted using these anthroposophical complexes as treatment and then growing bacterial 
cultures from swabs taken from the patients’ eyes at various stages of treatment to examine 
any anti-bacterial effects these complexes may have on Staphylococcus aureus in-vivo. 
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1. INTRODUCTION 
 
 
Bacterial Conjunctivitis is an acute or a chronic inflammation of the conjunctival 
epithelium of the eye 1 most commonly caused by the bacteria Staphylococcus aureus  2 . 
 
A common allopathic treatment used in cases of Staphylococcal Conjunctivitis is 
Chloramphenicol. Although this treatment is effective in 99% of patients with superficial 
eye infection 3, its contra-indications and serious side effects limits its use and safety. 
Staphylococcus aureus consistently adapts itself to become resistant to allopathic drug 
therapy. As a result, many antibiotics soon become ineffective in treating Staphylococcus 
aureus infections including those of the eye 4. The problems encountered when using this 
antibiotic establish the need to find alternative treatments that will be more gentle on the 
patient. 
 
Alternative treatments for Staphylococcal Conjunctivitis may be shown in the two 
anthroposophical complexes Echinacea / Quartz Complex Single Dose Eyedrops (Wala) 
and Euphrasia Single Dose Eyedrops (Wala), which are currently being used as an 
anthroposophical and a homoeopathic treatment of Bacterial Conjunctivitis. However, it 
has not yet been established whether or not these two preparations have a direct anti-
microbial action on the aetiological agents of Bacterial Conjunctivitis. 
 
Hence susceptibility testing was indicated for Staphylococcus aureus warranting anti-
microbial chemotherapy – which in this case was Echinacea / Quartz Complex Single Dose 
Eyedrops (Wala) and Euphrasia Single Dose Eyedrops (Wala). Two methods routinely 
used in susceptibility testing, namely the Agar Dilution Method and the Agar Disc 
Diffusion Method, were used. 
 
1.1 Aim 
 
The aim of this study is to determine the effect of the two anthroposophical complexes, the 
first being Echinacea/ Quartz Complex Single Dose Eyedrops (Wala) – made up of 
Echinacea e planta tota ferm D2, Argentum Metallicum D29, Quartz D19, Atropa 
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Belladonna ex herba ferm D14, Roseae aetheroleum D7; and the second, Euphrasia single 
dose Eyedrops – prepared from Euphrasia e planta tota ferm 33c D2 and Roseae 
aetheroleum D7, on the growth of Staphylococcus aureus in-vitro.  
 
1.2 Staphylococcus aureus 
 
1.2.1 Morphology and structure 
 
Staphylococcus aureus is a gram-positive, cluster forming coccus. Each coccus is about 
1λm in diameter 5 and is a non-sporing, non-motile organism. Although usually non-
capsulate, some strains produce a polysaccharide capsule that may help resist phagocytosis 
1. Staphylococcus aureus cocci have no specific arrangement under the microscope so they 
look like arrays of buckshot or bunches of grapes (“staphylo” comes from the Greek word 
for grapes) 6. 
 
When placed on nutrient agar for 24 hours at 37ºC, individual Staphylococcus aureus 
colonies grow. These colonies are circular, 2 – 3mm in diameter, opaque and frequently 
pigmented (golden-yellow fawn, or cream) with a smooth, shiny and mucosal surface 1. 
 
However, all staphylococcal members make large, creamy colonies on nutrient agar and in 
a large gram stain they all look like clusters of grapes. Thus, Staphylococcus aureus is best 
distinguished from other species of the genus (namely Staphylococcus epidermidis and 
Staphylococcus saprophyticus) using the coagulase test. Typical Staphylococcus aureus 
strains secrete an extracellular enzyme called coagulase (which clots plasma) that is not 
produced by other staphylococcal species. There are however, rare coagulase-negative 
strains of Staphylococcus aureus but these can be confirmed by detection of DNAase or 
protein A on the bacterial cell wall. 
 
1.2.2 Pathogenesis and pathology 
 
Staphylococcus aureus causes more frequent and more varied diseases in man than perhaps 
any other human pathogen 6. It is the most pathogenic species of the genus Staphylococcus 
as it produces a wide variety of enzymes and toxins that are thought to contribute to the 
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development of disease. The important enzymes include catalase, coagulase, leukocidin; 
and the toxins (which belong to the family of molecules known as superantigens) are 
TSST, enterotoxin, and exfoliatin. As a result Staphylococcus aureus produces invasive 
and toxin diseases. The invasive diseases vary from a superficial pustule or boil to 
conjunctivitis, wound infections, abscesses of deep soft tissues, brain or lung, or even 
osteomyelitis and septicaemia. The toxic diseases, which depend on the action of the 
Staphylococcus aureus toxins, include TSS (Toxic Shock Syndrome), Scalded Skin 
Syndrome, and food poisoning 5. 
 
Staphylococcus aureus is naturally found on the skin of healthy adults and on the mucosal 
surfaces especially on the anterior nares of about 30% of healthy adults, the groin, and the 
perineum 7. With an optimally functioning immune system, man can coexist with these 
potentially pathological micro-organisms. 
 
For a Staphylococcus aureus infection to occur, the bacteria need to invade the host tissue 
via a breach in the epithelium or mucosal barriers e.g. the conjunctiva. Once the 
Staphylococcus aureus bacteria have entered the mucus membrane, a fibronectin-binding 
protein (FNBP) on the surface of the bacteria allows them to attach to the exposed 
fibronectin in the wound. Here they evade or neutralise the host defences and destroy the 
host tissues. The survival of Staphylococcus aureus in the tissue depends on several 
factors: the number of bacteria entering the site, the site involved, the speed with which the 
body mounts an inflammatory response, and the immunological history of the host. The 
host’s immune response is directed at containing and eliminating the bacteria, principally 
by recruiting polymorphonuclear cells to phagocytose the bacteria and form collections of 
pus – abscesses – which are typical of staphylococcal infections. However, many of the 
virulence factors of Staphylococcus aureus are designed to either avoid their phagocytosis 
or to allow their survival in the phagocytes once they have been taken up: some 
Staphylococcus aureus strains are surrounded by a capsule that prevents their 
phagocytosis; the cell wall murein of Staphylococcus aureus activates compliment via the 
alternate pathway causing an inflammatory response (it resembles the endotoxin of a gram-
negative bacteria); the cell wall teichoic acid also activates compliment and allows for the 
adherence of the bacteria to the mucosal cells; the cell wall protein A binds non-
specifically to the Fc terminus of the IgG antibodies to incapacitate them; the bacteria 
produce enzymes and toxins with specific functions – leukocidin damages white blood 
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cells, catalase decreases the killing by phagocytes, coagulase causes plasma to clot, 
hemolysin lyses red blood cells, hyaluronidase may help the bacteria spread by destroying 
the host’s connective tissue ground substance, β-lactamase inactivates penicillins, 
exfoliatin causes sloughing of the skin in scalded skin syndrome, enterotoxin causes food 
poisoning, and TSS toxin is involved in Toxic Shock Syndrome 6. 
 
 
 
 
Figure 1.1 Virulence properties of Staphylococcus aureus in purulent discharge formation 
as in the case of a purulent bacterial conjunctivitis 6. 
 
 
Hence, the natural abundance and virulence of Staphylococcus aureus makes it the most 
common bacterial cause of conjunctivitis and it is transmitted into the eye by direct contact 
or via fingers or towelling 5. 
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1.3 Conjunctivitis and its aetiology 
 
1.3.1 The Conjunctiva and its function 
 
The conjunctiva is the thin, transparent mucus membrane that lines the posterior surface of 
the lids (the palpebral conjunctiva), extends into the space between the lid and the globe, 
and spreads over the anterior surface of the sclera (the bulbar conjunctiva). It is continuous 
with the skin at the lid margin, and the caruncle located at the inner canthus of the eye, and 
with the corneal epithelium at the limbus 7; 8. 
 
The conjunctival epithelium consists of 2 to 5 layers of basal and superficial stratified 
columnar epithelial cells. Near the limbus, over the caruncle, and near the mucocutaneous 
junctions at the lid margins, it consists of stratified squamous epithelial cells. The 
superficial epithelial cells contain round or oval mucus-secreting goblet cells. The mucus 
they produce is necessary for the proper dispersion of the precorneal tear film. Below the 
epithelial layer is the conjunctival stroma which is further divided into a superficial 
adenoid layer and a deeper fibrous layer. The adenoid layer contains lymphoid tissue. The 
fibrous layer lies loosely over the globe and is composed of connective tissue that is 
responsible for attaching the conjunctiva to the tarsal plate. The conjunctival stroma houses 
accessory lacrimal glands which produce secretions (tears) which contain lysozyme and 
other anti-microbial substances and keep the conjunctiva moist. The stroma contains the 
conjunctival blood vessels which are derived from the anterior ciliary and palpebral 
arteries as well as the nerves which arise from the opthalmic division of the Trigeminal 
nerve (5th Cranial Nerve) 8.  
 
The conjunctiva functions to protect the underlying sclera and lids from mechanical 
damage as well as acting as the host’s first line of defence against exogenous micro-
organisms which alight onto the conjunctiva when the eye is open. Micro-organisms, e.g. 
Staphylococcus aureus, which land on the conjunctiva are treated like inanimate particles 
of dust and are mechanically swept away by the formation of tears (by the lacrimal and 
accessory lacrimal glands) and the blinking of the eyelids moving the bacteria into the 
nasal cavity so that there is little opportunity for infection of the conjunctiva 9. 
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The healthy conjunctiva of the eye may harbour a number of skin organisms. Among those 
most frequently recovered from the healthy eye are Staphylococcus aureus, Streptococcus 
pyogenes, pneumococcus and neisseriae 10. If the conjunctiva is injured (e.g. when 
something gets into the eye) the opportunity arises for a micro-organism to enter the 
wound and cause conjunctivitis. 
 
1.3.2 Conjunctivitis 
 
Conjunctivitis is an acute or chronic inflammation of the conjunctival epithelium 2 which 
varies in severity from a mild hyperaemia with tearing to a severe conjunctivitis with a 
purulent discharge. It is the most common eye infection encountered in medical practice 5. 
This is because the conjunctiva is exposed to many micro-organisms and other noxious 
substances that can irritate the eye, allowing bacteria, viruses, and allergies to be the most 
common causes of conjunctivitis 7. 
 
1.3.3 Bacterial Conjunctivitis 
 
Bacterial conjunctivitis is the inflammation of the conjunctiva due to infection with 
bacteria 11. The bacterial agents damage the conjunctival epithelium causing epithelial 
oedema, cellular death and exfoliation, and epithelial hypertrophy, as well as oedema of 
the conjunctival stroma and hypertrophy of the adenoid layer of the stroma causing the 
formation of follicles. Plasma cells may be seen in the stroma and so are inflammatory 
cells (neutrophils/ eosinophils/ basophils/ lymphocytes, the presence of which indicate the 
nature of the damaging agent) which migrate from the conjunctival stroma, through the 
epithelium to the surface of the conjunctiva where they combine with fibrin and with the 
mucus produced by the conjunctival goblet cells to form a conjunctival exudate to catch 
the bacteria (hence the gumming of the eyelids on waking) and then excrete them along the 
nasal passages  A predominance of polymorphonuclear leukocytes in this exudate is 
characteristic of bacterial conjunctivitis. 
 
This reaction accounts for the following signs and symptoms in the patient: hyperaemia (a 
brilliant red suggests bacterial conjunctivitis) due to the appearance of a course network of 
the conjunctival blood vessels which cause the conjunctiva to lose its transparency and 
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smoothness and makes the eyes feel hot. A copious, flaky, amorphous exudation causes a 
mild gumming of the lids on waking. There is papillary hypertrophy because the 
inflammatory exudate accumulates between the fibrils that bind the conjunctiva down to 
the underlying tarsus or limbus and heap the conjunctiva into mounds (a red papillary 
conjunctiva suggests bacterial disease the eye and making the eyes feel heavy; the 
papillary hypertrophy and the conjunctival).  Chemosis, oedema of the conjunctival 
stroma, causes swelling and follicle formation giving the sensation of fullness around the 
eye and the feeling that there is sand or a foreign body in the eye, which in turn causes 
tearing. There may be the formation of phlyctenules (small whitish pustules) which 
represent a delayed hypersensitivity reaction to the microbial antigen especially 
staphylococcal antigens 2; 8. In bacterial conjunctivitis the iris remains clear and bright, the 
pupils react readily to light, and the cornea is clear 2. If, however, the infection complicates 
and the cornea becomes involved, then there is photophobia and pain.  
 
Bacterial conjunctivitis is usually a self-limiting infection lasting 10 to 14 days. This is due 
to the following factors: tears, abundant lymphoid elements in the conjunctival stroma, 
constant conjunctival epithelial exfoliation, and a cool conjunctival sac due to tear 
evaporation. The bacteria are caught in the conjunctival mucus and are then excreted by 
pumping action of the tear drainage system away from the eyes into the nasal passages 8; 12. 
Staphylococcal conjunctivitis may progress to a blepharoconjunctivitis including the 
eyelids and may enter a chronic phase which may not be self-limited and instead become a 
troublesome therapeutic problem. Hence, two types of bacterial conjunctivitis are 
recognised: acute and chronic. 
 
1.3.3.1 Acute Bacterial Conjunctivitis 
 
The organisms that commonly cause acute bacterial conjunctivitis are Staphylococcus 
aureus (often associated with blepharitis, phlyctenules, and marginal sterile infiltrates), 
Streptococcus pneumoniac, Haemophilus influenza (especially in children), 
Staphylococcus epidermidis  1, 11, 12, 13.  Of these Staphylococcus aureus is the most 
common 5. 
 
The infection usually starts in one eye and is spread to the other eye by the hands, towels, 
etc causing bilateral irritation and injection. It is characterised by an acute onset of 
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conjunctival hyperaemia and a profuse purulent or a moderate mucopurulent discharge; 
occasionally there are small subconjunctival haemorrhages. Other signs include enlarged 
conjunctival papillae, chemosis, and it typically occurs without preauricular adenopathy. 
 
Direct examination and conjunctival swabs for routine culture studies and Gram’s Stains or 
Geimsa’s Stains are used to isolate the specific causative bacteria and to reveal the 
polymorphonuclear neutrophils respectively. Antibiotic sensitivity tests are done but 
empirical antibiotic therapy is usually started using a broad-spectrum antibiotic and then 
when the results of the antibiotic sensitivity tests become available, specific antibiotic 
therapy is then commenced. 
 
1.3.3.2 Chronic Bacterial Conjunctivitis 
 
Organisms that can cause an acute bacterial conjunctivitis to become chronic include 
Staphylococcus aureus, Moraxella lacunata, Pseudomonas, and Proteus. 
 
Chronic bacterial conjunctivitis occurs in patients with nasolacrimal duct obstruction. It is 
associated with chronic bacterial blepharitis (especially in staphylococcal infections) and 
with meibomianitis. It is usually a unilateral irritation and presents with chronic red eyes, 
burning, itching, and a mild mucopurulent discharge 11. Marginal corneal ulceration may 
follow infection with Staphylococcus aureus. 
 
1.4    Treatment of Bacterial Conjunctivitis 
 
If left untreated, bacterial conjunctivitis generally lasts 10 to 14 days, but more rapid 
resolution (1 to 3 days) is usually achieved with the use of topical antibiotics 8; 12. 
 
A common antibiotic treatment used in cases of staphylococcal conjunctivitis is 
chloramphenicol 3; 14. 
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1.4.1 Chloramphenicol 
 
Chloramphenicol is a broad-spectrum bacteriostatic antibiotic which exhibits a wide range 
of inhibitory activity against gram-positive, gram-negative, aerobic and anaerobic bacteria 
12. It is effective against mycoplasma, chlamydiae, and rickettsia. As a result, it is 
therapeutically used to treat a wide range of diseases: ocular infections (where topical 
chloramphenicol is effective against Staphylococcus aureus, Streptococcus pneumoniac, 
Escherischia coli, Neisseria, Haemophilus influenzae, Enterobacter, Klebsiella, and 
Moraxella species); bacterial meningitis; anaerobic infections (e.g. brain, abdominal, or 
pelvic abscesses); typhoid fever; rickettsial disease; and brucellosis. 
 
Its chemical names include: 
(a) acetamide,2,2-dichloro-N-[2-hydroxy-1-(hudroxymethyl)-2-(4-nitrophenyl)ethyl], 
(b) D-threo-(-)-2,2-dichloro-N-[beta-hydroxy-alpha-(hydroxymethyl)-p-
nitrophenyl]acetamide. 
Its structure/ molecular formula is: 
 
                                                                 OH 
                                                                 ⏐   CH2OH        O 
                                                                 ⏐   ⏐                  ⎥ ⎢ 
O2N ⎯     O     ⎯CHCH ⎯ NH⎯C⎯CHCL2
 
Chloramphenicol was originally derived from Streptomyces venezuelae and was first used 
to treat an outbreak of typhus in Bolivia. In the eye, chloramphenicol was initially used to 
treat intraocular infections and was administered systemically. Now it is available in oral, 
intravenous, and tropical forms such as Chloromycetin Ophthalmic Solution 0,5% (Parke-
Davis) which contains 5mg/ml of Chloramphenicol. 
 
It is bacteriostatic as it inhibits protein synthesis by reversibly binding to the ribosomal 
peptidyl transferase of the bacteria and prevents the binding of amino acids containing 
tRNA to the acceptor site on the 50S ribosome of the bacteria 15; 16, and to a lesser degree, 
in eucaryotic cells (cells of the higher organisms containing a true nucleus bounded by a 
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nuclear membrane) as it may inhibit mitochondrial protein synthesis because mitochondrial 
ribosomes closely resemble bacterial ribosomes. Chloramphenicol is 50% protein bound. 
 
Ocular penetration of this antibiotic occurs after system, subconjunctival, or topical 
application. In patients undergoing routine cataract surgery, aqueous levels of 3 to 6 μg/ml 
were obtained 2 hours after topical application of 0,5% chloramphenicol drops every 5 
minutes for 6 doses 17. 
 
Chloramphenicol is metabolised by the liver where it is converted to the inactive 
glucuronide. It is then cleared from the body through the kidneys and is excreted in the 
urine. Patients with renal insufficiency or cirrhosis of the liver using the drug will have 
increased levels of chloramphenicol in their blood due to decreased metabolic inactivation 
of the medicament. This may cause problems in patients with anaemia because 
chloramphenicol may inhibit the patient’s response to iron and B12 therapy. Hence it is 
contraindicated in anaemic patients undergoing treatment. 
 
It is contraindicated in patients sensitive to it as it may cause nausea, vomiting, stomatitis, 
diarrhoea, and local irritation with subjective symptoms of itching or burning, vesicular or 
macular dermatitis, urticaria, angioneurotic oedema, and fever. Although usually well 
tolerated on the eye surface, topically applied chloramphenicol may induce a local 
hypersensitivity reaction associated with burning and stinging and sometimes even 
depigmentation 8. Other side effects include optic neuritis – histological examinations of 
children treated with chloramphenicol have shown demyelination of the papillomacular 
bundle, and optic atrophy in children with cystic fibrosis. Systemic administration can lead 
to problems with colour vision, allergic conjunctivitis, mydriasis, and retinal oedema. 
 
Chloramphenicol’s most serious side effect is on the bone marrow where it causes either a 
dose-related and reversible anaemia with occasional leukopenia and thrombocytopaenia 
and eventually a reticulocytopaenia due to it inhibiting the host mitochondrial protein 
synthesis, or it causes a usually irreversible aplastic anaemia characterised by a peripheral 
pancytopaenia and an aplastic bone marrow. Although it occurs more commonly after 
prolonged systemic use of chloramphenicol, aplastic anaemia and death has been reported 
after a short course of topical chloramphenicol drops and ointment 8. 
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Another potentially fatal side effect associated with high serum levels of chloramphenicol 
is Gray Syndrome in babies. Gray Syndrome usually presents itself four days after 
treatment is initiated. Symptoms include vomiting, refusal to suck, abdominal distension, 
cyanosis, lethargy, gray stools, the skin has an ashen colour, and there is tachypnea. It may 
lead to acidosis and vasomotor collapse and even death in 40% of patients. This occurs 
because chloramphenicol causes an inhibition of host mitochondrial electron transport in 
the liver, myocardium, and in the skeletal muscle. Chloramphenicol can pass through the 
placenta and is present in breast milk, thus its use should be avoided in lactating women or 
pregnant women near term. 
 
Chloramphenicol may cause the overgrowth of non-susceptible organisms including fungi. 
 
Bacterial resistance normally develops relatively slowly to chloramphenicol but 
Staphylococcus aureus is becoming increasingly resistant to many antibiotics causing the 
danger that the organism may mutate to form chloramphenicol resistant strains – already 
staphylococcal resistance to chloramphenicol has been increasing and may be due to 
chloramphenicol acetyltransferase 4; 8; 15. 
 
The limitations and side effects encountered when using this antibiotic establish the need 
to find safer and more gentle alternative treatments for bacterial conjunctivitis. Such 
medicaments may be found in Homoeopathy and in Anthroposophical medicine. 
 
1.4.2 The Principles of Homoeopathy and Anthroposophy 
 
1.4.2.1 The Principles of Homoeopathy 
 
Homoeopathy is a system of therapeutics that, like anthroposophical medicine, considers 
disease and its associated bacteria, viruses and other organisms to be caused by a 
disharmony in the body which allows the infectious organism to flourish. True healing 
occurs when the disharmony is corrected so that the noxious agent no longer has a ground 
on which it can thrive. Each patient uses his/ her defence mechanisms to get rid of the 
agent in an individual way. Therefore it considers the human being as a whole 18. 
 
 11
The word “homoeopathy” is derived from the Greek words “homoios” – meaning like or 
similar, and “pathos” – which means suffering. This describes the main principle that 
homoeopathic therapeutics is base on – the Simile principle – like cures like i.e. any 
substance capable of causing certain symptoms in a healthy person is capable of curing 
similar symptoms in an ill person 19. 
 
To learn what symptoms a remedy can cure, the doctor must first know the forces inherent 
in that physical medicament. This knowledge of remedies has been (and still is) obtained 
through provings. A proving is a process whereby a group of healthy people are 
administered a particular substance thought to hold medicinal properties. All the changes 
that occur in their physical and mental state are reported and carefully recorded. This 
detailed description of all the signs and symptoms caused by the remedy is represented in 
the Homoeopathic Materia Medica 18. 
 
When treating a patient, the homoeopath must know all the patient’s mental, physical, 
general, and local symptoms so as to treat the patient as an individual. A particular remedy 
is then chosen from the homoeopathic materia medica on the basis that the greatest number 
of signs and symptoms observed in the patient most similarly match those signs and 
symptoms recorded in the provings of the remedy in question. Only the most similar 
remedy should be administered. This is the principle of the Single Remedy 18; 20. 
 
A suitable potency of the remedy must be chosen. Homoeopathic remedies are diluted, 
attenuated and dynamised through the process of potentisation. Potentisation is usually 
done using one of two scales: the centesimal scale where the dilution ratio is 1:100, or the 
decimal scale where the dilution ratio is 1:10. The homoeopathic remedies used in the 
anthroposophical complexes discussed in this study, were prepared according to the 
decimal scale. This means that one part of the original substance was added to nine parts of 
dilutent (usually alcohol and/ or distilled water, or lactose) and succussed or triturated a 
predetermined number of times to make the first decimal potency of the remedy, written as 
D1. To proceed further, one part of the new D1 solution is taken and added to nine parts of 
dilutent and succussed to make a D2 potency of the remedy. This process is repeated until 
the desired potency is reached 21. In homoeopathy, succussion involves the repeated, firm, 
downward striking of the closed bottle filled with a medicament onto a firm surface (the 
anthroposophical remedies used in this study were succussed using a method called 
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rhythmic succussion where the remedy is succussed in a gentle rhythm with no collision) 
22. This process gives energy to the remedy or dynamises the remedy. (All the remedies 
used in the two anthroposophical complexes tested in this study, were made up in distilled 
water and not in alcohol to avoid stinging the eyes as they are eyedrops). 
 
Once the most similar remedy and the correct potency is decided upon, it is administered to 
the patient. Homoeopathic remedies aim to regulate and enhance the efficiency of the 
immune system of the individual they are being administered to 21. 
 
1.4.2.2 The Principles of Anthroposophy 
 
Anthroposophical medicine was initially developed by the Austrian scientist and 
philosopher Rudolf Steiner (1860 – 1925) and Dutch physician Ita Wegman 23. This form 
of medicine treats every person as an individual because illness is individualised by the 
person harbouring it. It has a wholistic approach to healing and aims to treat the body, 
mind, spirit and soul using prescribed herbal and homoeopathic preparations (if necessary, 
conventional drugs are used). 
 
Anthroposophy incorporates such a wide variety of treatments because it considers the 
human being in relation to the three kingdoms of nature: 
The mineral kingdom - which is structure only, with no life of its own e.g. a stone, does not 
move unless an external force moves it. The “physical body” of the human being is created 
by the life forces taking up minerals into the form of the etheric body. The skeleton is the 
most stone-like (and most mineralised) part of the human body and most nearly approaches 
and approximates the mineral kingdom. 
The plant kingdom, where plants have physical structure but, unlike stones, plants have a 
life force. This life force enables plants to grow, to have shape, to multiply and to live. 
This is called the “etheric body”. 
The third kingdom is the animal kingdom. An animal has both a physical body and an 
etheric body (just like a plant does), but an animal can also achieve a certain level of 
conscious awareness. It has feelings which are expressed through drives, desires, pain and 
pleasure. In anthroposophy, animals are considered to be “ensouled beings” with feelings. 
This is called the “astral body”. 
 13
Human beings have a physical body, an etheric body and an astral body. Humans also 
possess a self awareness that enables them to think, speak, and consciously develop. This 
is called the “ego”. The ego is what makes human beings unique 24. 
 
Human beings share all 3 kingdoms of nature. This fact enables them to use substances that 
come from any of these 3 kingdoms to treat illnesses within themselves. 
 
Anthroposophy considers the human body as being made up of 3 functional systems which 
normally interact harmoniously with each other, maintaining the health of the individual. 
The first system is the Sense-Nervous System (The Head System). Nerves run throughout 
the human body but the main centre of the nervous system is in the head and the spinal 
cord. This centre is the physical basis of waking consciousness, sense perception, ideation, 
and the formation of mental images. It is also responsible for the cooling and hardening 
processes that occur in the body. These processes are known to increase in old age and 
over activity in this system can, for example, cause arthritis. 
The second system is the Reproductive-Metabolic System (The Assimilating or Digestive 
System). It is centred below the diaphragm and includes the limbs and the digestive 
system. This centre is the physical basis of more subconscious processes of physical life – 
it comprises the actual transformation of material in the body and is associated with the 
building up and enlivening processes in the body. This system works in the realm of 
warmth and softening, so over activity of this centre causes inflammatory illnesses and 
conditions often associated with childhood e.g. fevers, mumps. 
The third system is the Rhythmic System (The Chest System). Within this system is 
situated the heart and lungs as well as the circulation. It balances the Sense-Nervous 
System and the Reproductive-Metabolic System and is responsible for feelings, which in 
turn are based on the rhythmic processes of breathing and the circulation of blood. 
For each human being the interaction between these three functional systems is individual 
and specific and determines his health 23; 24. 
 
Illness is seen as a result of disharmony, which causes an imbalance in the relationship 
between the 3 functional systems that make up the person. It is this picture of man that is 
used in anthroposophical medicine to identify the illness, e.g. if a patient has a bacillus 
infection (as in staphylococcal conjunctivitis), the anthroposophical doctor will consider 
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the patient in such a way as to recognise how he/ she has become the bearer of the specific 
bacilli in question (as do homoeopaths). 
 
The doctor then needs to apply the most specific medicament. To do this, though, the 
anthroposophical doctor must first know the forces inherent in the physical medicaments in 
nature. This is where homoeopathy plays an important role in anthroposophical medicine 
23. 
 
Rudolf Steiner found that plants which are abnormally proportioned in their morphology 
tend to display medicinal qualities. An ideally proportioned plant has perfect harmony 
between flower, leaf and root (just as the three functional systems in the human body are in 
harmony when the person is healthy). Just as an imbalance between the three functional 
systems in the human body causes illness, an imbalance between the three parts of the 
plant demonstrates a potential healing quality in the plant. 
 
The flower, leaf and root of the plant relate directly to the three functional systems in a 
person: The root of the plant is cold and hard – relating to the cold, hard human sense-
nervous system centred in the head. The leaves of the plant absorb gasses and capture the 
sun’s energy in their chlorophyll, they relate to the human rhythmic system which contains 
the breathing and circulatory organs (the lungs and the heart). The flowers and fruit of the 
plant relate to the human reproductive–metabolic system 24.  
 
This knowledge of the substances of nature, combined with the understanding of the 
human functional systems and the relationships which exist between the human organism 
and nature, allows the anthroposophical doctor to apply the most specific medicament for 
each patient. 
 
1.4.3 The Anthroposophical Complexes 
 
1.4.3.1 Echinacea/ Quartz Complex Single Dose Eyedrops (Wala) 
 
Echinacea/ Quartz Complex Single Dose Eyedrops (Wala) is an anthroposophical 
preparation widely used to treat superficial eye infections 25. It is sold in Germany, Austria, 
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Switzerland, Finland, Holland, Denmark, Norway, England, Ireland, Scotland, Wales, 
Poland, Italy, Canada, the United States of America, New Zealand, and South Africa 26.  
 
The complex was developed to increase immunity in non-specific conjunctival 
inflammation 27. It is indicated in superinfection in allergic inflammation of the 
conjunctiva 28 and in acute suppurative conjunctivitis 25. 
 
It is prepared from the following remedies: Echinacea e planta tota ferm D2, Argentum 
metallicum D29, Quartz D19, Atropa belladonna ex herba ferm D14, Rosae aetheroleum 
D7. Homoeopathically the remedies used in this complex are included based on the 
symptoms they cause in their provings that are similar to those symptoms caused by 
bacterial conjunctivitis 25. 
 
1.4.3.1.1 Action of the ingredients in terms of the Anthroposophical model 
 
Anthroposophical principles dictate that the mineral kingdom bears a direct relationship to 
the ego body, the plant kingdom to the soul body (the astral body) and the animal 
substances to the life body (the etheric body), so the formulations of the eyedrops were 
devised according to these relationships.  
 
The formula for the Echinacea/Quartz Complex Single Dose Eyedrops (Wala) was 
developed to treat acute and subacute purulent and allergic conjunctival inflammation 27. 
The preparation does this by stimulating the warmth-Ego-organisation in cases of weak 
etheric organisation in the conjunctival region (as in superinfection in allergic conjunctival 
inflammation) i.e. it stimulates the building up processes in the body that make 
polymorphonuclear leukocytes which will then be transported to the conjunctiva to kill the 
bacteria, it does this when the conjunctival cells are not regenerating themselves and are 
not multiplying to form new healthy ones to maintain the integrity of the eye. A weak 
etheric organisation renders the human body as susceptible to invasion by foreign life e.g. 
Staphylococcus aureus in bacterial conjunctivitis. The Echinacea e planta tota ferm D2, 
the Argentum metallicum D29, and the Quartz D19 all act through the warmth processes 
on the Ego-organisation to stimulate metabolic activity and other building up processes to 
increase the immune functions of the eye and the conjunctiva. The Atropa belladonna ex 
herba ferm D14 acts on the astral body to hold back the excessive arterial blood process in 
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the eye to dissolve the inflammatory focus so that the tissue can regenerate 27; 29. The 
Rosae aetheroleum D7 works via the blood on the warmth process of the eye to harmonise 
and subdue the excessive metabolic-blood processes in the eye (which cause redness and 
swelling of the conjunctiva) that occur in bacterial conjunctivitis. 
 
By using complexes it is possible to obtain effects on different levels of the organism 
simultaneously, to re-establish a healthy relationship between the levels at the respective 
site in the organism. Medicinal products of this type work together with the body’s own 
functions, regulations and control processes, enhancing or stimulating them, or subduing 
them if they have become too active 29.  
 
Echinacea e planta tota ferm D2 acts as an anti-inflammatory. Echinacea is used to treat 
acute autoinfections and septic conditions generally 30 because it is believed to act as an 
antibiotic 31 and as an antitoxin for internal and external infections 32. Echinacea has a 
special relationship to warmth and therewith to sulphuric metabolic processes. It stimulates 
metabolic activity and connective tissue to increase immune functions and leukocyte 
proliferation. Echinacea has an affinity for weakened sensory processes and acts on the 
matrix tissue of the eye 27. 
 
 Argentum metallicum D29 controls inflammation and is thought to be antibacterial in 
action. Provings done on Argentum metallicum show that it causes the eyelids to become 
red and thick and the eyes are worse for touch – as in conjunctivitis 30. It works through the 
etheric forces in the human body. Etheric forces are mainly connected with metabolism 
and growth but over activity here causes inflammation. Argentum metallicum brings order 
and rhythm to these excessive etheric-inflammatory activities in the eye 27; 33. 
 
Quartz D19 controls inflammation and reduces mucopurulent discharge. 
Homoeopathically, Quartz is known as Silica and it is used to treat suppurative processes 
(as in a suppurating bacterial conjunctivitis) because it works to expel foreign objects and 
related infections 20. Silica’s symptom picture includes swelling of the lachrymal duct, eyes 
are tender to touch and are worse for closing the eyelids, the angles of the eyes are 
commonly affected, and there is an aversion to light especially to daylight 30. This light 
sensitivity indicates that Quartz is connected with the light ether and so has a strong 
connection to the eye 33. Quartz works in the realm of warmth and has an affinity for the 
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physical body, so it strengthens the form qualities in organs – in this case the eye. It will 
help the conjunctiva overcome the excessive inflammatory activity so evident in bacterial 
conjunctivitis 27. 
 
Atropa belladonna ex herba ferm D14 acts as an anti-inflammatory 25 and as a spasmolytic. 
Homoeopathically, Belladonna is characterised by a sudden onset of symptoms 20. 
Belladonna displays symptoms of photophobia and spasms of the eye when the eye senses 
light 34. It causes heat, redness, throbbing and burning in the eyes; the eyes feel swollen 
and dry, and the conjunctiva is red. Anthroposophically, the redness of the eyes in this 
remedy’s symptom picture is key to its inclusion in this complex: Atropa belladonna acts 
on the astral body to overcome the arterial hyperaemia that occurs in bacterial 
conjunctivitis by holding back the excessive arterial blood process in the eye during 
inflammation 27. 
 
Rosae aetheroleum D7 balances the circulation in the eye. It works via the blood on the 
warmth processes of the eye. It is used as a capillary tonic and thus acts as an anti-
inflammatory 32.  
 
This preparation does not contain alcohol 25 because alcohol would cause stinging of the 
eyes and thus exacerbate the symptoms. 
 
Echinacea/ Quartz Complex Single Dose Eyedrops (Wala) is contra-indicated in patients 
who are sensitive to any of its active ingredients and as a result, the only possible known 
side effect is an allergic reaction to it 28. 
 
1.4.3.2 Euphrasia Single Dose Eyedrops (Wala) 
 
Euphrasia Single Dose Eyedrops (Wala) contains two homoeopathic remedies – Euphrasia 
e planta tota ferm 33cD2 and Rosae aetheroleum D7 35. 
 
Euphrasia officinalis has been used in ophthalmic medicaments since the 16th century 36. It 
is used to treat bacterial conjunctivitis because the symptoms mentioned in the symptom 
picture of both homoeopathic remedies used to make up this anthroposophical preparation 
occur in bacterial conjunctivitis 30; 31; 32. 
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The Euphrasia Single Dose Eyedrops (Wala) are used in anthroposophical medicine to 
restructure the fluid organism of the eye 36. i.e. in bacterial conjunctivitis, the sense-
nervous system of the eye becomes aware that the conjunctiva has been damaged by 
bacteria; in response to this irritation, the rhythmic system of the body increases its blood 
flow to the eye so as to deliver polymorphonuclear leukocytes to the conjunctiva to kill the 
bacteria, and to deliver nutrients to the conjunctiva to heal the damaged conjunctival 
epithelium. This process causes the redness, the swelling and the other symptoms that the 
patient experiences in bacterial conjunctivitis. The medicament harmonises the relationship 
between the rhythmic system (which is increasing the blood flow to the conjunctiva, 
making the eye very red and swollen) and the sense-nervous system (which is being 
irritated by the presence of bacteria on the conjunctiva and the damaged conjunctival 
epithelial cells, and is thus stimulating the rhythmic system to increase the blood flow to 
the conjunctiva) of the patient concentrating on the scleral region of the eye 27 to reduce 
these symptoms. This is because the main ingredient of the preparation, the Euphrasia e 
planta tota ferm 33cD2, possesses a strong astral activity (multiplication of new cells and 
regeneration of damaged cells of the conjunctiva) which promotes vitality in the eye by 
stimulating connective tissue in cases of etheric exhaustion of the eye (when cells are not 
multiplying or regenerating) due to excessive sensory processes from being irritated by the 
bacteria present on the conjunctiva. The Rosae aetheroleum D7 is active in the warmth 
processes of the eye (where there is an increase of blood flow to the eye causing redness 
and swelling of the conjunctiva) so it works to harmonise them. This is important because 
inflammatory illnesses develop when there is over activity in the warmth and softening 
realm of the body. 
 
Euphrasia e planta tota ferm 33cD2, according to the anthroposophical model, has been 
used because of its ability to reduce the inflammation of mucous membranes (especially of 
the eye) and to promote vitality by stimulating the connective tissue of the eye 27. It can do 
this because, as a plant, it is a semi-parasite living on the roots of grasses. It has reduced its 
metabolic powers and instead lets itself be nourished by the grass so that it can concentrate 
all its energy into its flowers. This enhances its connection with light and in turn with the 
eye and sensory perception. Its root suckers draw nourishment from the roots of 
neighbouring grasses allowing this plant to have a harmonising and subduing effect on 
excessive metabolic blood processes particularly in the nerve-sense region and the eye 
when used as a remedy i.e. it reduces the redness of the conjunctiva in conjunctivitis 27. 
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Homoeopathically Euphrasia officinalis manifests itself by inflaming the conjunctival 
membrane and causing irritation in the eye. This is why it is indicated in catarrhal 
conjunctivitis with an acrid discharge coming from the eyes, burning and swelling of the 
lids, and the formation of pus at the inner and outer canthi causing the eyes to be 
agglutinated in the morning 30; 31; 32; 37. The profuse tears leave a varnish trail on the cheeks 
20 and the discharge is worse in hot rooms 34. 
 
Rosae aetheroleum D7 is included in this preparation because it is a capillary tonic which 
balances the circulation in the eye. It works via the blood on the warmth processes of the 
eye to act as an anti-inflammatory 32. 
 
This preparation does not contain alcohol 35 so as not to sting the eyes and exacerbate the 
symptoms. However, the low potency of the Euphrasia in these eyedrops may cause 
sensitive people to experience a slight burning sensation when instilling the drops, but this 
declines with use and as inflammation subsides 27. A significant advantage of this complex 
is that it does not contain any preservatives, so it is well suited for long-term use. 
 
A study using this anthroposophical preparation was conducted in Germany on 65 patients. 
The symptoms of conjunctivitis that were investigated were reddening, swelling, secretion, 
burning of the conjunctiva, and foreign body sensation. They were documented separately 
for the right eye and the left eye using 4 degrees of severity: not available, mild, medium, 
and severe in relation to baseline, after 7 (±3) days, and after 14 (±3) days. Tolerability was 
examined after 7 (±3) days, and after 14 (±3) days. The parameters used to investigate 
tolerability were: conjunctival reddening, burning of the conjunctiva, foreign body 
sensation, veiled vision, and undesired effect due to the medication. Both the doctor and 
the patient gave an evaluation of the efficacy and the tolerability of the therapy at the end 
of the treatment 36. 
 
The prospective cohort trial found that a dosage of 3 times a day proved to be optimal in 
the majority of patients and that the average treatment period was 11 days. The difference 
between maximum and minimum was 14 days (3 or 17 days). The treatment lead to a 
complete disappearance of symptoms within 3 to 17 days in more than 95% of the patients. 
There were no side effects, however a mild irritation of the eyes occurred in 1 of the 65 
cases. Efficacy was described by patients and doctors as good to very good in about 88% 
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of the cases. Tolerability was described as good to very good in 94% to 97% of the cases 
36. 
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2. MATERIALS AND METHODS 
 
 Materials 
 
 Stock cultures 
 
Twenty Staphylococcus aureus specimens were obtained from Van Drimmelin 
Laboratories. The laboratory positively identified all twenty isolates. These specimens 
were stored under refrigeration at 4 – 8°C. 
 
 Media 
 
All media used in this study was stored at 4 - 8°C (but was allowed to equilibrate to room 
temperature before use). All media (pre-prepared and prepared) was used within 7 days of 
manufacture. A sample from each batch of media was incubated for 48 hours to assess 
sterility. Samples of peptone water were incubated for 24hrs and then cultured onto 
nutrient agar plates and incubated for a further 24 hours to assess sterility. 
 
2.1.2.1  Nutrient agar 
 
The nutrient agar used in this study was manufactured by Oxoid Limited. It was prepared 
according to manufacturer instructions 38. This agar was used to subculture the isolates, 
and as the medium that the anthroposophical remedies were mixed in for the agar dilution 
method as well as the control plates for this test. 
 
The nutrient agar plates were prepared as follows: 
• 28g of nutrient agar was suspended in 1000ml of distilled water. 
• The suspension was heated to boiling point until the powder was dissolved completely 
• The pH was measured to be 7.5, no adjustment was necessary because 7.5 is the pH 
needed for optimum growth of Staphylococcus aureus. 
• The solution was then poured into 500ml screw-top bottles and sterilised by being 
autoclaved at 121°C for 15 minutes. 
• The flasks were placed in a water bath and allowed to cool to 50°C. 
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• Approximately 25ml of the agar was poured into each 9mm petri dish, lying on a flat 
surface, to obtain a depth of 3 – 4mm of agar in each dish. 
• The agar plates were allowed to cool and solidify at room temperature. 
• The plates were then packaged in plastic, sealed, turned upside down, and refrigerated 
at 4 – 8°C while a sample was assessed for sterility. 
 
2.1.2.2  Peptone water 
 
Tubes containing peptone water were obtained from the South African Institute of Medical 
Research. These nutrient broth tubes were used to prepare the inoculum in the agar dilution 
method and in the disc diffusion test. 
 
2.1.2.3  Chloramphenicol plates 
 
Pre-prepared nutrient agar plates containing chloramphenicol at the established minimum 
inhibitory concentration (MIC90) of 8mg/l were obtained from the South African Institute 
of Medical Research. The MIC90 is the lowest concentration of antimicrobial agent that 
completely inhibits the growth of at least 90% of the organism 39. These plates were used 
in the agar dilution method. 
 
2.1.2.4  Mueller-Hinton agar 
 
Pre-poured Mueller-Hinton agar plates were obtained from the South African Institute of 
Medical Research. They were used in the disc diffusion method. 
 
 The anthroposophical complexes 
 
 Echinacea/ Quartz Complex Single Dose Eyedrops (Wala) 
 
The Echinacea/ Quartz Complex Single Dose Eyedrops (Wala) were purchased from 
Pharma Natura (PTY) Ltd, Wynberg, S.A. They were stored in the refrigerator at 4 - 8°C 
until use. 
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 Euphrasia Single Dose Eyedrops (Wala) 
 
The Euphrasia Single Dose Eyedrops (Wala) were purchased from Pharma Natura (PTY) 
Ltd, Wynberg, S.A. They were stored in the refrigerator at 4 - 8°C until use. 
 
 Chloramphenicol discs 
 
Chloramphenicol discs containing 10μg of chloramphenicol were purchased from Davies 
Diagnostics, JHB, S.A. They were used in the disc diffusion method. 
 
 Sterile paper discs 
 
Sterile paper discs were obtained from Davies Diagnostics, JHB, S.A. They were used on 
their own as a control, or saturated with the anthroposophical complex remedies in the disc 
diffusion test. 
 
 0,5 McFarland standard 
 
The McFarland standard used in this study was obtained from the South African Institute 
of Medical Research. 
 
 Methods 
 
 Aseptic techniques 
 
In order to maintain the scientific integrity of the laboratory work done during the research 
i.e. to prevent any kind of contamination, aseptic techniques were adhered to at all times. 
The aseptic techniques used were: 
• Disinfecting the working area before and after laboratory work 
• Using only sterile media which was either pre-sterilised or was autoclaved at 121°C for 
20 minutes during its manufacture. 
 24
• Sterilising the inoculation loop before and after each step. The loop was sterilised by 
“flaming” it over a Bunsen burner until the wire became red hot. (The loop was 
allowed to cool before use so as not to kill the bacteria in the stock cultures). 
• Flaming the necks of test tubes before and after each step. 
• Using different pre-sterilised pipette tips for each step. 
 
 Maintenance of Staphylococcus aureus 
 
This study utilised twenty isolates of Staphylococcus aureus obtained from and positively 
identified by Van Drimmelin Laboratories. Each isolate was subcultured onto separate 
nutrient agar plates, using the streak plate method, and clearly labelled with its own 
number (1 – 20). 24 hours before testing started, the isolates were subcultured onto nutrient 
agar plates, as tests were conducted on 18 – 24 hour isolates. Each isolate was subcultured 
onto correctly numbered nutrient agar plates every 48 hours until testing was complete. 
 
The streak plate method was used to ensure individual colony growth as opposed to carpet 
growth so that it would be easier to select single discrete colonies when inoculating the 
peptone water in the agar dilution method and the Mueller-Hinton agar in the disc diffusion 
test. This method involved: 
• A single colony of Staphylococcus aureus was removed from the original agar plate 
with a flamed and cooled inoculating loop. 
• The loop, full of Staphylococcus aureus bacteria, was then used to streak the bacteria 
across ¼ of the plate in parallel strokes of 3 or 4 rows. 
• The inoculating loop was flamed to sterilise it and then it was cooled by inserting it 
into the agar at the edge of the nutrient agar plate. 
• The loop was then streaked across the previous streaks at approximately a 60° angle to 
those streaks to create another 4 parallel rows in the second quadrant of the agar plate 
(this ensures as much spread across the plate as possible). 
• The loop was again flamed and cooled. 
• The streaking process was repeated, taking bacteria from the second quadrant and 
streaking them into the third quadrant of the plate. 
• The loop was sterilised and cooled. 
 25
• The streaking was repeated once more to spread the bacteria from the third quadrant 
into the fourth quadrant of the plate. 
 
The plates were then correctly numbered stacked 5 plates high and incubated for 24 hours 
at 37°C and thereafter refrigerated upside down at 4 - 8°C. 
 
 The agar dilution method 
 
This method for determining antimicrobial susceptibility is a well-established technique 40 
whereby the antimicrobial agent is directly incorporated aseptically into the agar and the 
inoculum is then applied to the agar surface. After incubation the colonies are counted and 
converted to obtain the colony forming units per millilitre. 
 
 Preparation of the agar 
 
• The nutrient agar was prepared as outlined in 2.1.2.1. 
• Before the cooled agar was poured into the petri dishes, each anthroposophical remedy 
was individually added to the molten agar using sterilised pipettes. The amount of 
remedy added was determined by the “Dilution Scheme for Reference Method”: one 
part of antimicrobial complex was added to nine parts of liquid agar, as recommended 
by the National Committee for Clinical Laboratory Standards 39. As one batch of agar 
yielded 1000ml, 100ml of the prepared anthroposophical complex was added to 900ml 
of nutrient agar to get a dilution ratio of 1:10. 
• The plates were then poured as outlined in 2.1.2.1 and were allowed to cool and 
solidify at room temperature. 
• They were then packaged, sealed in plastic, turned upside down and refrigerated at 4 - 
8°C until needed. 
• One plate from each batch of each remedy and of the control plates was incubated at 
37°C for 48 hours to assess sterility. 
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 Chloramphenicol plates 
 
• Pre-prepared nutrient agar plates with chloramphenicol at the established MIC90 of 
8mg/l 39 already incorporated into the agar were used. 
• The plates were refrigerated at 4 – 8 °C until needed. 
• One plate from the batch of chloramphenicol plates was incubated at 37°C for 48 hours 
to assess sterility. 
 
 Preparation of the inoculum 
 
2.2.3.3.1 Turbidity standard for inoculum preparation 
 
To standardise the inoculum density for the susceptibility test, a BaSO4 turbidity standard, 
equivalent to a 0,5 McFarland standard, was used. 
 
The correct density of the McFarland standard used in this study was verified with a 
spectrophotometer: the absorbance at 625nm should have been between 0.08 and 0.10 for 
the 0,5 McFarland standard, for this study the reading was 0.092. 
 
The actively growing broth cultures were then optically compared to the 0,5 McFarland 
standard and each suspension was adjusted to match this turbidity standard so that the 
resulting suspensions would each contain approximately 1 x 108CFU/ml. 
 
Throughout the study the standard was stored in a cupboard – in the dark and at room 
temperature. 
 
2.2.3.3.2 The direct colony suspension method 
 
• Several well-isolated colonies were selected from an 18 – 24 hour plate. A flamed wire 
loop, which had been cooled on the agar before touching the colonies, was used to 
touch the top of each colony. 
• This was then inoculated into a correspondingly labelled tube containing 5ml of 
peptone water. The mouth of the tube had been flamed before inoculation. 
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• This was repeated for each of the twenty specimens. 
• Each inoculated peptone water culture was then incubated at 37°C until it visually 
appeared to match or exceed the turbidity of the McFarland standard. 
• The turbidity of the actively growing broth cultures were individually adjusted with 
sterile peptone water to obtain a turbidity optically comparable to that of the 0,5 
McFarland standard to ensure that each suspension would have a resulting inoculum 
concentration of 1 x 108CFU/ml. 
• Using a dilution ratio of 1:10, the culture was diluted with sterile peptone water so that 
the resulting suspension would contain the desired concentration of 1 x 107CFU/ml 40. 
 
2.2.3.4  Inoculation of the agar plates 
 
• Disposable sterile pipette tips were used to aliquot 2μl of inoculum onto the agar plate. 
This yielded a final inoculum concentration of 1 x 104CFU/ml. Separate pipette tips 
were used for each inoculum. 
• A flamed loop was then used to streak the inoculum evenly across the plate to allow for 
a possible carpet growth of the Staphylococcus aureus isolate on the agar plate. 
• The inoculation onto the plates was done in triplicate for each inoculum with each 
remedy complex, chloramphenicol, and control plates containing only agar and no 
medicament. 
• The plates were inverted, stacked 5 plates high, and incubated at 37°C for 24 hours. 
• The number of colonies per plate were counted and recorded. 
 
2.2.4  The disc diffusion test 
 
This method is used to classify the organisms as susceptible, resistant or intermediate to 
the antimicrobial agents in question 41. The discs used will have been saturated with the 
antimicrobial agent, which in turn diffuses through the agar, creating a gradient of drug 
concentrations in the agar medium surrounding each disc. After incubation a clear zone 
(the zone of inhibition) is present around the disc if the agent inhibits bacterial growth, if 
not, then the organism grows right up to the disc 41. The wider the zone of inhibition, the 
more susceptible the pathogen to the antimicrobial agent and the lower the minimum 
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inhibitory concentration of medicament needed to treat the patient infected with the strain 
tested. 
According to the National Committee for Clinical Laboratory Standards guidelines, the 
definitions for the zone sizes are: 
• sensitive – the zone diameter is equal to, wider than, or not more than 6mm smaller 
than that of the chloramphenicol discs – this implies that the infection is likely to 
respond to the antimicrobial treatment. 
• resistant – the zone diameter is 10mm or less, which implies that the infection is 
unlikely to respond to the antimicrobial treatment. 
• intermediate – the zone diameter is greater than 10mm but is smaller than the zone 
diameter of the chloramphenicol discs by more than 6mm – this implies that an 
intermediate response to antimicrobial treatment is likely. 
 
2.2.4.1  The Mueller-Hinton agar 
 
Pre-prepared Mueller-Hinton agar plates were used. Mueller-Hinton agar was the medium 
of choice as it allows for satisfactory growth of most pathogens. 
 
2.2.4.2  Preparation of the paper discs 
 
• Sterile paper discs were placed into sterile petri dishes using flamed forceps. These 
petri dishes were individually labelled with the name of the anthroposophical complex 
that they were to be saturated with. 
• The paper discs were then saturated with the corresponding remedy and allowed to dry 
in a lamina flow unit. 
• A sample disc from each batch was placed onto a nutrient agar plate and incubated at 
37°C for 48 hours to assess sterility. 
• Pre-prepared chloramphenicol discs containing 10μg of chloramphenicol 39 were used. 
They were store unopened at 4 - 8°C and only removed from the refrigerator 2 hours 
before use (so that they could warm to room temperature before use to minimise 
condensation on the cold discs when they come into contact with the warm laboratory 
air). 
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2.2.4.3  Preparation of the inoculum 
 
The inoculum was prepared using the direct colony suspension method, as described in 
2.2.3.3.2. 
 
2.2.4.4  Inoculation of the agar plates 
 
• A sterile cotton swab was dipped into the broth culture suspension within 15 minutes of 
adjusting the turbidity of the inoculum. The swab was rotated a few times and the 
excess culture was squeezed onto the inside of the test-tube above the fluid level. 
• The swab was then streaked over the entire sterile Mueller-Hinton agar surface of a 
correspondingly labelled plate. The plate was rotated at approximately 60° and re-
streaked. This was done once more to ensure even distribution or carpet growth of 
inoculum. Then the rim of the agar was swabbed. 
• The culture was allowed to dry for 3 –5 minutes at room temperature. 
• This was repeated three times for each inoculum. 
 
2.2.4.5  Application of the discs 
 
• Using a flamed needle, four discs (each remedy on individual discs, a chloramphenicol 
disc, and a control disc which remained unmedicated) were placed, evenly spaced, onto 
each inoculated plate. Each disc was pressed down firmly to ensure complete contact 
with the agar surface. The needle was flamed between each disc. 
• The plates were inverted, stacked 5 high, and incubated for 24 hours at 37°C. 
• After incubation, the zones of inhibition were measured to the nearest whole millimetre 
with sliding callipers and the unaided eye. The measurements were made on the agar 
surface and not through the plastic bottom or the lid of the dish. The zones of inhibition 
were measured from the edge of the disc to the edge of the zone. The zone margin was 
taken to be the area showing no obvious visible growth. No colonies were observed 
growing within the clear zones of inhibition. 
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3 RESULTS 
 
The antimicrobial activity of two anthroposophical complexes, namely Echinacea/ Quartz 
Complex Single Dose Eyedrops (Wala) and Euphrasia Single Dose Eyedrops (Wala), and 
the antibiotic chloramphenicol were measured against the growth of the pathogenic 
bacteria Staphylococcus aureus. 
 
The average and primary colony count values and the disc diffusion zone sizes for the 
twenty isolates with and without treatment are available in Appendix A and Appendix B, 
respectively. 
 
3.1 Results of the agar dilution method 
 
This method of testing was used to compare the number of colonies that grew on each plate 
after a standard inoculum of Staphylococcus aureus (which yielded a final inoculum 
concentration of 1 x 104CFU’s) was inoculated onto the plates containing either 
anthroposophical remedy, or chloramphenicol, or no medication at all (control plates). 
 
The control plates were inoculated to assess bacterial growth and to yield initial colony 
counts for each specimen. The mean colony count for the control plates was 122 colonies 
per plate. 
 
The plates containing chloramphenicol were inoculated to confirm the accuracy and 
success of the testing methodology. The concentration of chloramphenicol used was 8mg/l, 
the established MIC90 for chloramphenicol (the lowest concentration of antimicrobial agent 
that completely inhibits growth of at least 90% of the organism) 39. The mean colony count 
for the chloramphenicol plates was 0 colonies per plate. The control counts were then 
compared to the colony counts obtained from the plates containing chloramphenicol: the 
colony counts on the chloramphenicol containing plates were reduced by a mean of 100%. 
This confirmed that the testing methodology was accurate. 
 
The mean colony count obtained for the Echinacea/ Quartz Complex Single Dose 
Eyedrops (Wala) was 121 colonies per plate. 
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The mean colony count obtained for the Euphrasia Single Dose Eyedrops (Wala) was 121 
colonies per plate. 
 
 
 
Figure 3.1.1 Bar chart showing the mean colony count per plate of Staphylococcus aureus 
grown on media containing either an anthroposophical complex, or chloramphenicol, or 
control plates containing no antimicrobial agent. 
 
 
The colony counts were then analysed using a two way analysis of variance. First the 
individual bacterial isolates were analysed against an F distribution of approximately 1.66 
at 95% stat. with 19 and 120 degrees of freedom. The result was 5.98, which means that 
the isolates did have an effect on how well the treatments worked. Then the two 
anthroposophical complexes and the control (chloramphenicol colony counts were all 0 
cfu/ml) were analysed against an F distribution of 3.07 at 95% stat. with 2 and 120 degrees 
of freedom. The resulting F distribution was 0.11, which showed that the treatment type 
did not effect the result. Thirdly, the interactions between the bacteria and each of the 
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antimicrobial agents were analysed against an F distribution of approximately 1.55 at 95% 
stat. with 38 and 120 degrees of freedom. The result of 0.01 showed no interaction between 
the two variables, i.e. different treatments did not react differently to the different bacterial 
isolates, the agents were constant in their reactions to the individual Staphylococcus aureus 
isolates. 
 
 
Table 3.1.1 Results of the two-way analysis of variance  
 
Source Degrees of Freedom (df) 
Sum of Squares 
(SS) 
Mean Square 
(SS/df) F Distribution 
Bacteria 19 42698.80 2247.31 5.98 
Treatments 2 80.74 40.37 0.11 
Interaction 38 141.70 3.73 0.01 
Error 120 45117.91 375.98  
 
 
To summarise, although there was a decrease in the number of colonies of bacteria per 
plate due to the anthroposophical complexes there was no significant difference between 
the anthroposophical treatments themselves and when compared to the control counts. The 
results also showed that, the effect was significantly less than the decrease in the number of 
colonies due to chloramphenicol. 
 
3.2 Results of the disc diffusion test 
 
Each Staphylococcus aureus isolate was plated three times onto media to which paper 
discs impregnated with either anthroposophical complex remedy, or with chloramphenicol, 
or no medication at all (control discs) were applied. 
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The zone sizes were measured in millimetres using sliding callipers and were rounded up 
to the nearest millimetre. 
 
There was confluent bacterial growth up to the disc margins of the plain paper discs, i.e. no 
zone sizes appeared for the control discs. 
 
There was confluent bacterial growth up to the disc margins of those discs impregnated 
with the anthroposophical complexes, Echinacea/Quartz Complex Single Dose Eyedrops 
(Wala) or Euphrasia Single Dose Eyedrops (Wala), resulting in no zones around those 
discs. 
 
Discs impregnated with the antibiotic chloramphenicol were used to confirm the accuracy 
and success of the testing methodology. The zone sizes for the 10μg chloramphenicol discs 
all measured 18 mm or more and had a mean zone size of 19mm. This confirmed that the 
testing methodology was correct and accurate. 
 
 
Table 3.2.1 The mean values, standard deviations, and 95% confidence intervals of the 
zone diameters for each anthroposophical remedy, the chloramphenicol, and the control 
discs. 
 
Antimicrobial 
Agent 
Mean Zone Size Standard Deviation 95% stat 
Echinacea/Quartz 
Complex 
0 0 0 
Euphrasia 
Eyedrops 
0 0 0 
Chloramphenicol 19 1 [18, 20] 
Control Discs 0 0 0 
 
 34
0
2
4
6
8
10
12
14
16
18
20
Control Echinacea/Quartz
Complex
Euphrasia Chloramphenicol
Antimicrobial Agents
M
ea
n 
Zo
ne
 S
iz
es
 
Figure 3.2.1 The results of the statistical comparisons of the zone sizes around the discs 
impregnated with either of the two anthroposophical remedies, or with chloramphenicol, or 
the control discs. 
 
 
Each zone size was then categorised as sensitive, intermediate, or resistant and compared 
using the Chi-square test (the Chi-square test could, however, not be done as there were no 
recorded zone sizes for either of the anthroposophical remedies). The chloramphenicol 
zone sizes were compared to the already established data for its sensitivity i.e. ≥ 18mm 42. 
As all the zones for the chloramphenicol discs were ≥ 18mm, each Staphylococcus aureus 
specimen was classified as sensitive to the antibiotic, as was expected 42. According to the 
National Committee for Clinical Laboratory Standards criteria for the definitions of zone 
sizes, the Staphylococcus aureus isolates were all resistant to the Echinacea/Quartz 
Complex Single Dose Eyedrops (Wala), as well as to the Euphrasia Single Dose Eyedrops 
(Wala). Table 3.2.2 illustrates this categorisation where: 
• sensitive – denotes a zone diameter equal to, wider than, or not more than 6mm 
smaller than that of the chloramphenicol discs – this implies that the infection is likely 
to respond to the antimicrobial treatment, and 
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• resistant – denotes a zone diameter of 10mm or less, which implies that the infection is 
unlikely to respond to the antimicrobial treatment. 
 
 
Table 3.2.2 Comparison of the interpretation of the zone sizes (as sensitive or resistant) 
surrounding the discs containing either anthroposophical remedy or 10μg of 
chloramphenicol. 
 
Antimicrobial 
Agent 
Number of 
Sensitive Bacteria 
Number of 
Resistant Bacteria 
Chi-square 
Statistic 
Echinacea/Quartz 
Complex 
0 60 Not applicable 
Euphrasia 
Eyedrops 
0 60 Not applicable 
Chloramphenicol 60 0 Not applicable 
 
 
The results of the disc diffusion test show that there is a significant difference between the 
action of the chloramphenicol and the two anthroposophical remedies on the growth of 
Staphylococcus aureus in-vitro. They also show that there is no difference between the 
anthroposophical complexes themselves, nor is there a difference between the 
Echinacea/Quartz Complex Single Dose Eyedrops (Wala), the Euphrasia Single dose 
Eyedrops (Wala), and the non-medicated discs on the growth of Staphylococcus aureus in-
vitro. 
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4. DISCUSSION 
 
The agar dilution method 
 
In this study, the efficacy of the Echinacea/Quartz Complex Single Dose Eyedrops (Wala) 
and the Euphrasia Single Dose Eyedrops (Wala) was determined by the degree to which 
each anthroposophical preparation inhibited the growth of Staphylococcus aureus in-vitro 
when compared to the effects of the control and of the chloramphenicol. 
 
The methodology used adhered to the guidelines for antimicrobial susceptibility testing set 
out by the National Committee for Clinical Laboratory Standards 40: a standard inoculum 
of bacteria was plated onto agar containing the agent of interest, and was incubated for a 
standard period of time. The resulting colonies were counted and analysed. 
 
From the bar chart (Fig 3.1.1) depicting the mean colony count values for the 
Echinacea/Quartz Complex Single Dose Eyedrops (Wala), Euphrasia Single Dose 
Eyedrops (Wala), control plates (media containing no active agent), and chloramphenicol, 
it seems that there is no significant difference between the control plates and either 
remedy. There is no significant difference between the anthroposophical remedies 
themselves. However, when compared to the chloramphenicol plates, there is a large 
difference: the chloramphenicol proved to be an effective antibacterial agent as there was 
no growth on any of the chloramphenicol plates. 
 
According to the results of the two-way analysis of variance, it is evident that neither the 
Echinacea/Quartz Complex Single Dose Eyedrops (Wala) nor the Euphrasia Single Dose 
Eyedrops (Wala) demonstrated a significant antimicrobial effect on the Staphylococcus 
aureus isolates in-vitro. It confirms that there was no significant difference between the 
effects of the anthroposophical complexes themselves. However, the bacterial isolates did 
have a statistically significant effect on how well the anthroposophical remedies worked, 
but there was no interaction between the bacteria and either of the anthroposophical 
complexes i.e. the different bacteria did not influence how well the remedies worked with 
respect to each other. 
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The disc diffusion test 
 
The methodology used in this part of the study adhered to the guidelines for antimicrobial 
susceptibility testing as set out by the National Committee for Clinical Laboratory 
Standards 41. The agent of interest was applied to sterile paper discs that were then applied 
onto the agar plates containing a uniform growth of bacteria, and incubated for a standard 
period of time. The resulting zones of inhibition were then measured and analysed. 
 
Table 3.2.1 and Fig 3.2.1 show the mean zone sizes around the discs impregnated with 
either Echinacea/Quartz Complex Single Dose Eyedrops (Wala), Euphrasia Single Dose 
Eyedrops (Wala), chloramphenicol, or with no medication at all (the control discs). These 
results reflect no clear zones of inhibition of Staphylococcus aureus around the discs 
containing Echinacea/Quartz Complex Single Dose Eyedrops (Wala), Euphrasia Single 
Dose Eyedrops (Wala), or control discs. This means that neither anthroposophical 
treatment produced significant results in the disc diffusion test when compared to each 
other and to the control discs, and that neither displayed any antimicrobial activity on 
Staphylococcus aureus in-vitro. The chloramphenicol did however prove to be effective as 
an antimicrobial treatment. There is a significant difference between the action of the 
chloramphenicol and the two anthroposophical remedies on the growth of Staphylococcus 
aureus in-vitro. 
 
The study results are internally consistent. 
 
 The efficacy of the Anthroposophical Complexes 
 
The aim of this study was to determine whether or not the Echinacea/Quartz Complex 
Single Dose Eyedrops (Wala) and the Euphrasia Single Dose Eyedrops (Wala) displayed 
anti-bacterial properties by determining the degree to which each complex inhibited the 
growth of Staphylococcus aureus in-vitro. The results were compared to the effects of the 
control and the chloramphenicol on Staphylococcus aureus in-vitro. There were no 
differences between the anthroposophical medicines and the control, but the 
chloramphenicol did prove to be antibacterial. The study indicates that neither 
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anthroposophical preparation displayed any antimicrobial activity against the 
Staphylococcus aureus in-vitro. 
 
The results of this study conflict with prior clinical data where a prospective cohort trial of 
the Euphrasia Single Dose Eyedrops (Wala) was conducted on 65 patients with 
inflammatory or catarrhal conjunctivitis. The trial concluded that the Euphrasia Single 
Dose Eyedrops (Wala) is a very effective medication for inflammatory and catarrhal 
conjunctivitis with a complete disappearance of symptoms within 3 to 17 days in more 
than 95% of the patients it was tested on 35. It showed that the complex is well tolerated 36. 
 
A possible explanation for the conflicting results may be found in the mechanism of action 
to be found in anthroposophical and homoeopathic treatments. Bearing in mind that 
Staphylococcus aureus is naturally found on the skin and the mucosal surfaces of healthy 
adults, an adequately functioning immune system keeps Staphylococcal infections at bay. 
In anthroposophy, illness is seen as an imbalance in the relationship between the 3 
functional systems of man. Both anthroposophical and homoeopathic remedies enhance the 
body’s ability to heal itself because the mechanisms for functioning of the remedies are on 
the whole person and not on the infectious organism. This is why it is not surprising to find 
these results. However, any therapy which harnesses the body’s own antimicrobial activity 
warrants further investigation. 
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5. CONCLUSIONS AND RECOMMENDATIONS 
 
Conclusions 
 
In this study, no differences were demonstrated between the anthroposophical preparations 
and the media or discs containing no active agent in-vitro. In conclusion, this study 
indicates that neither Echinacea/Quartz Complex Single Dose Eyedrops (Wala) nor 
Euphrasia Single Dose Eyedrops (Wala) display antimicrobial activity against 
Staphylococcus aureus in-vitro. Furthermore, there is no significant difference in the effect 
on Staphylococcus aureus in-vitro between the complexes themselves. 
 
Prior clinical data demonstrates that the Euphrasia Single Dose Eyedrops (Wala) is 
effective in treating patients with conjunctivitis. This suggests that the anthroposophical 
complexes stimulate the human body to heal itself. 
 
Recommendations 
 
An in-vivo study should be conducted to determine whether these anthroposophical 
complexes have an effect on the growth and colonisation of Staphylococcus aureus on the 
conjunctiva of the eye. The in-vivo study could use swabs taken from the conjunctiva of 
each patient suffering from Staphylococcal Conjunctivitis to grow Staphylococcus aureus 
colonies on non-medicated nutrient agar plates. Swabs should be taken every day over a 
period of 1 week from patients being treated with the anthroposophical remedies in 
question as well as from a control group where the patients are being treated with an 
allopathic antibiotic. The number of colonies on each agar plate should then be counted 
and compared to each other. Disc diffusion tests could be done to ensure internally 
consistent results throughout the study.  
 
These two anthroposophical complexes could also be tested on other organisms known to 
cause conjunctivitis (other bacteria or fungi) to determine whether or not they exhibit in-
vitro and even in-vivo antimicrobial action against those organisms. 
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APPENDIX A 
 
Table A1 
Colony counts obtained from control plates containing no antimicrobial agent. The control 
plates were individually inoculated with the twenty isolates of Staphylococcus aureus. 
Each specimen inoculation contained approximately 1 x 104CFU. 
 
SPECIMEN ID TRIAL 1 TRIAL 2 TRIAL 3 MEAN 
COLONY 
COUNT 
1 125 125 127 126 
2 106 110 109 108 
3 103 100 99 101 
4 114 117 109 113 
5 115 112 121 116 
6 136 148 129 138 
7 157 135 142 145 
8 109 111 107 109 
9 113 118 109 113 
10 114 112 119 115 
11 128 131 139 133 
12 162 164 169 165 
13 119 112 109 113 
14 123 111 120 118 
15 145 139 149 144 
16 111 109 120 113 
17 133 128 140 137 
18 107 103 106 105 
19 119 113 121 118 
20 123 119 128 123 
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Table A2 
Colony counts obtained from agar plates containing Euphrasia Single Dose Eyedrops 
(Wala). Each Staphylococcus aureus specimen inoculation contained approximately 1 x 
104CFU. 
 
SPECIMEN ID TRIAL 1 TRIAL 2 TRIAL 3 MEAN 
COLONY 
COUNT 
1 120 121 124 122 
2 105 108 107 107 
3 100 102 99 100 
4 110 117 112 113 
5 116 113 118 116 
6 140 140 138 139 
7 152 139 140 144 
8 106 110 107 108 
9 111 117 108 112 
10 114 110 120 115 
11 125 130 134 130 
12 164 159 164 162 
13 116 111 108 112 
14 121 113 117 117 
15 139 140 147 142 
16 110 116 114 113 
17 129 126 138 131 
18 104 107 103 105 
19 113 116 118 116 
20 124 118 125 122 
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Table A3 
Colony counts obtained from agar plates containing Echinacea/Quartz Single Dose 
Eyedrops (Wala). Each Staphylococcus aureus specimen inoculation contained 
approximately 1 x 104CFU. 
 
SPECIMEN ID TRIAL 1 TRIAL 2 TRIAL 3 MEAN 
COLONY 
COUNT 
1 120 122 126 123 
2 106 108 108 107 
3 98 99 99 99 
4 113 112 110 112 
5 113 115 118 115 
6 138 143 137 139 
7 146 131 140 139 
8 108 109 106 108 
9 114 115 110 113 
10 113 114 117 115 
11 125 129 136 130 
12 164 164 169 166 
13 117 112 108 112 
14 119 112 119 117 
15 137 138 142 139 
16 109 110 117 112 
17 131 129 137 132 
18 103 104 108 105 
19 115 114 116 115 
20 118 121 129 123 
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Table A4 
Colony counts obtained from agar plates containing chloramphenicol. Each 
Staphylococcus aureus specimen inoculation contained approximately 1 x 104CFU. 
 
SPECIMEN ID TRIAL 1 TRIAL 2 TRIAL 3 MEAN 
COLONY 
COUNT 
1 0 0 0 0 
2 0 0 0 0 
3 0 0 0 0 
4 0 0 0 0 
5 0 0 0 0 
6 0 0 0 0 
7 0 0 0 0 
8 0 0 0 0 
9 0 0 0 0 
10 0 0 0 0 
11 0 0 0 0 
12 0 0 0 0 
13 0 0 0 0 
14 0 0 0 0 
15 0 0 0 0 
16 0 0 0 0 
17 0 0 0 0 
18 0 0 0 0 
19 0 0 0 0 
20 0 0 0 0 
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APPENDIX B 
 
Table B1 
Zone sizes, measured in millimetres, for all Staphylococcus aureus specimens tested 
against the control discs (sterile plain paper discs). 
 
SPECIMEN ID TRIAL 1 (mm) TRIAL 2 (mm) TRIAL 3 (mm) MEAN ZONE 
SIZE (mm) 
1 0 0 0 0 
2 0 0 0 0 
3 0 0 0 0 
4 0 0 0 0 
5 0 0 0 0 
6 0 0 0 0 
7 0 0 0 0 
8 0 0 0 0 
9 0 0 0 0 
10 0 0 0 0 
11 0 0 0 0 
12 0 0 0 0 
13 0 0 0 0 
14 0 0 0 0 
15 0 0 0 0 
16 0 0 0 0 
17 0 0 0 0 
18 0 0 0 0 
19 0 0 0 0 
20 0 0 0 0 
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Table B2 
Zone sizes, measured in millimetres, for all Staphylococcus aureus specimens tested 
against discs impregnated with the Euphrasia Single Dose Eyedrops (Wala). 
 
SPECIMEN ID TRIAL 1 (mm) TRIAL 2 (mm) TRIAL 3 (mm) MEAN ZONE 
SIZE (mm) 
1 0 0 0 0 
2 0 0 0 0 
3 0 0 0 0 
4 0 0 0 0 
5 0 0 0 0 
6 0 0 0 0 
7 0 0 0 0 
8 0 0 0 0 
9 0 0 0 0 
10 0 0 0 0 
11 0 0 0 0 
12 0 0 0 0 
13 0 0 0 0 
14 0 0 0 0 
15 0 0 0 0 
16 0 0 0 0 
17 0 0 0 0 
18 0 0 0 0 
19 0 0 0 0 
20 0 0 0 0 
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Table B3 
Zone sizes, measured in millimetres, for all Staphylococcus aureus specimens tested 
against discs impregnated with the Echinacea/Quartz Single Dose Eyedrops (Wala). 
 
SPECIMEN ID TRIAL 1 (mm) TRIAL 2 (mm) TRIAL 3 (mm) MEAN ZONE 
SIZE (mm) 
1 0 0 0 0 
2 0 0 0 0 
3 0 0 0 0 
4 0 0 0 0 
5 0 0 0 0 
6 0 0 0 0 
7 0 0 0 0 
8 0 0 0 0 
9 0 0 0 0 
10 0 0 0 0 
11 0 0 0 0 
12 0 0 0 0 
13 0 0 0 0 
14 0 0 0 0 
15 0 0 0 0 
16 0 0 0 0 
17 0 0 0 0 
18 0 0 0 0 
19 0 0 0 0 
20 0 0 0 0 
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Table B4 
Zone sizes, measured in millimetres, for all Staphylococcus aureus specimens tested 
against discs impregnated with chloramphenicol. 
 
SPECIMEN ID TRIAL 1 (mm) TRIAL 2 (mm) TRIAL 3 (mm) MEAN ZONE 
SIZE (mm) 
1 18 18 19 18 
2 20 19 20 20 
3 20 20 20 20 
4 18 19 19 19 
5 20 19 20 20 
6 18 19 18 18 
7 19 19 19 19 
8 20 20 20 20 
9 19 19 19 19 
10 19 17 19 18 
11 19 18 18 18 
12 18 18 19 18 
13 20 19 18 19 
14 19 19 19 19 
15 18 18 18 18 
16 18 18 19 18 
17 18 18 19 18 
18 19 20 20 20 
19 20 19 19 19 
20 18 18 18 18 
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